FDA flags potential cardiac risk with evenamide Four deaths among evenamide-treated patients prompted FDA concerns about possible fatal arrhythmias, although a causal link remains unconfirmed. By Mouj Hijazi October 8, 2026 3 min MDSpire News Share Summary Takeaways Clinical Scorecard Quiz Poll
